Morgan Stanley raised the firm’s price target on Bayer (BAYRY) to EUR 28 from EUR 26 and keeps an Equal Weight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY:
- Bayer says FDA accepts NDA under priority review for sevabertinib
- Bayer price target raised to EUR 25 from EUR 22 at Barclays
- Trump Trade: Trump considers 50% tariff on EU, 25% on iPhones
- OTC Markets Group welcomes Bayer to OTCQX
- Trump admin report implies companies are worsening health of children, FT says